Ik Investment Partners in negotiation with Ardian for the acquisition of Kersia
The private equity firm IK Investment Partners has announced that the IK IX Fund has entered into negotiations with Ardian, a world-leading private investment house, to acquire a majority stake in Kersia.
Specialized in biosecurity and food safety, Kersia was established as a new company in 2016 after the Hypred’s acquisition of Antigerm, LCB Food Safety, G3, Kilco, Choisy Laboratories and Holchem. In the four years following Ardian’s investment, the company has tripled in size. Since 2016 Kersia has grown to become a global player in the field of biosafety and food safety. The company, which has a turnover of more than 300 million euros, operates today in more than 120 countries employing more than 1.500 people.
“With the support of Ardian, Kersia has notably deployed a strong sustainability roadmap. Leading a responsible growth strategy and the integration of six companies in such a short period of time requires first-rate skills and discipline. We are proud to have contributed to this success” commented Thibault Basquin, Head of Americas Investments for Ardian Buyout and Managing Director.